Pfizer shares sinking to March 2020 lows after the company halted its twice-daily weight loss pill. Just how big of a setback is this for the pharma heavyweight’s entry into the obesity drug race? The Fast Money traders debate.
Fast Money Disclaimer
Create your
podcast in
minutes
It is Free